ADC Therapeutics Files for IPO

Date : 09/07/2019 @ 12:26AM
Source : Dow Jones News
Stock : Astrazeneca Plc (AZN)
Quote : 7258.0  29.0 (0.40%) @ 4:35PM
Astrazeneca share price Chart

ADC Therapeutics Files for IPO

AstraZeneca (NYSE:AZN)
Historical Stock Chart

6 Months : From Jun 2019 to Dec 2019

Click Here for more AstraZeneca Charts.
   By Josh Beckerman 
 

Switzerland-based biotechnology company ADC Therapeutics SA has filed for an initial public offering.

ADC focuses on hematological malignancies and solid tumors.

The company plans to trade on the New York Stock Exchange under symbol ADCT. The filing lists an amount of $150 million.

Auven Therapeutics owns 42.7% stake of ADC. AstraZeneca PLC (AZN) owns 7.1%.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

September 06, 2019 20:11 ET (00:11 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191207 07:25:20